MAP Pharmaceuticals, Inc. (NQ:MAPP)
Delayed: 24.98 --0 (-0%)
Trade Now!
Previous Close $24.98    52 Week High $25.03 
Open $29.25    52 Week Low $11.11 
Day High $24.98    P/E N/A 
Day Low $24.98    EPS $-3.11 
Volume 236,653       

Friends, Peers and Foes (?): AGN, PATH, ZGNX, POZN, ACAD (more...)

Mar 1, 2013 12:52 PM UPDATE: Wedbush Downgrades MAP Pharma (MAPP) to Neutral, Notes Other Potential M&A Targets
Feb 1, 2013 10:56 AM Ladenburg Thalmann Downgrades MAP Pharmaceuticals (MAPP) to Neutral
Jan 28, 2013 09:02 AM Deutsche Bank Downgrades MAP Pharmaceuticals (MAPP) to Hold; Doesn't Expect Other Bids
Jan 24, 2013 08:43 AM Canaccord Genuity Downgrades MAP Pharmaceuticals (MAPP) to Hold
Jan 24, 2013 06:54 AM Leerink Swann Downgrades MAP Pharmaceuticals (MAPP) to Market Perform
Jan 23, 2013 01:02 PM Unusual 11 Mid-Day Movers 01/23: (MAPP) (CREE) (THLD) Higher; (STRI) (SMCI) (COH) Lower
Jan 23, 2013 10:04 AM Notable Mergers and Acquisitions of the Day 01/23: (AGN)/(MAPP) (CSCO) (WPI)
Jan 23, 2013 09:31 AM StreetInsider.com Pre-Open Movers 01/23: (MAPP) (CREE) (GOOG) Higher; (COH) (BNNY) (MCP) Lower (more...)
Jan 23, 2013 09:25 AM ACADIA Pharmaceuticals (ACAD) Sees Early Action on Partner Deal
Jan 23, 2013 07:23 AM NuPathe (PATH) on the Radar on Sector Deal
View All Articles

Entities mentioned with MAPP

View All Entities